Taiwan`s Tanvex BioPharma appoints Stephen Lam as CEO
05 Sep 2024 //
BIOSPECTRUM ASIA
Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
05 Sep 2024 //
PRESS RELEASE
Tanvex BioPharma Names New CEO
04 Sep 2024 //
CONTRACT PHARMA
Tanvex BioPharma USA Achieves Dual U.S. Regulatory Milestones
30 Aug 2024 //
CONTRACT PHARMA
Bora Pharma Invests In Tanvex To Expand Global Biomanufacturing Services
27 Aug 2024 //
PRESS RELEASE
Tanvex Biologic Nypozi (filgrastim-txid) Receives Approval in the US
28 Jun 2024 //
FDA